| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $6.2B | $6.1B | $5.8B | $1.4B | $1.3B | $2.0B | $6.5B |
| Cost of Revenue | $1.5B | $2.5B | $2.5B | $2.5B | $2.2B | $2.0B | $3.6B | $3.1B |
| Gross Profit | $0.7B | $3.7B | $3.6B | $3.4B | $0.8B | $0.8B | $1.0B | $0.9B |
| R&D Expense | $0.3B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.5B | $0.4B |
| SG&A Expense | $1.7B | $2.2B | $2.1B | $2.0B | $1.8B | $1.7B | $2.2B | $1.7B |
| Operating Income | $0.2B | $1.2B | $1.1B | $1.0B | $0.2B | $0.2B | $0.3B | $0.3B |
| Net Income | $0.6B | $0.8B | $0.9B | $0.8B | $0.2B | $1.2B | $0.2B | $2.1B |
| EPS (Basic) | $0.59 | $2.39 | $2.46 | $2.12 | $0.46 | $3.55 | $0.52 | $6.26 |
| EPS (Diluted) | $0.58 | $2.36 | $2.43 | $2.10 | $0.44 | $3.37 | $0.52 | $6.17 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.7B | $17.0B | $16.9B | $15.9B | $16.5B | $16.1B | $17.4B | $12.9B |
| Current Assets | $1.6B | $2.6B | $3.7B | $2.5B | $2.5B | $4.4B | $3.7B | $3.2B |
| Cash & Equivalents | $0.4B | $0.8B | $1.9B | $0.7B | $0.8B | $1.8B | $1.2B | $1.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.2B | $2.2B | $1.8B | $2.7B | $3.7B | $2.9B | $3.5B | $2.2B |
| Stockholders' Equity | $6.5B | $10.2B | $10.3B | $9.7B | $9.5B | $9.0B | $7.4B | $6.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.5B | $1.4B | $1.3B | $1.0B | $1.4B | $1.3B | $1.3B |
| Investing Cash Flow | $-0.1B | $-1.8B | $-0.2B | $-0.1B | $-2.6B | $-0.1B | $-4.1B | $-2.0B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-1.4B | $-0.8B | $0.0B | $-1.3B | $0.7B | $-0.7B | $2.8B | $0.9B |